Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality
Top Cited Papers
- 1 August 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 104 (3), 525-534
- https://doi.org/10.1002/jlb.5vmr0118-021rr
Abstract
Obesity and type 2 diabetes mellitus (T2D) are global pandemics. Worldwide, the prevalence of obesity has nearly tripled since 1975 and the prevalence of T2D has almost doubled since 1980. Both obesity and T2D are indolent and chronic diseases that develop gradually, with cellular physiologic changes occurring before the clinical signs and symptoms of the diseases become apparent. Individuals with obesity and T2D are physiologically frail and have an increased risk of infections and mortality from sepsis. Improvement in the morbidity and mortality of these at‐risk populations would provide a great societal benefit. We believe that the worsened outcomes observed in these patient populations is due to immune system dysfunction that is triggered by the chronic low‐grade inflammation present in both diseases. As immune modulatory therapies have been utilized in other chronic inflammatory diseases, there is an emerging role for immune modulatory therapies that target the chronically affected immune pathways in obese and T2D patients. Additionally, bariatric surgery is currently the most successful treatment for obesity and is the only weight loss method that also causes a sustained, substantial improvement of T2D. Consequently, bariatric surgery may also have a role in improving immunity in these patient populations.Keywords
Funding Information
- National Institutes of Health (GM-29507, GM-61656)
- Godfrey D. Stobbe Endowment
This publication has 72 references indexed in Scilit:
- High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cellsCardiovascular Diabetology, 2013
- Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 DiabetesPLOS ONE, 2013
- B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profileProceedings of the National Academy of Sciences, 2013
- The role of chemokines in recruitment of immune cells to the artery wall and adipose tissueVascular Pharmacology, 2009
- Extending international sepsis epidemiology: the impact of organ dysfunctionCritical Care, 2009
- Nutrient sensing and inflammation in metabolic diseasesNature Reviews Immunology, 2008
- Increased circulating regulatory T cells (CD4+CD25+CD127−) contribute to lymphocyte anergy in septic shock patientsIntensive Care Medicine, 2008
- Obesity induces a phenotypic switch in adipose tissue macrophage polarizationJCI Insight, 2007
- Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetesClinical and Experimental Immunology, 2006
- Islet cell failure in type 2 diabetesJCI Insight, 2006